DLI after haploidentical BMT with post-transplant CY

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

(2013) Merav Bar et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation

(2013) Amer M. Zeidan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

(2013) A Raiola et al.   BONE MARROW TRANSPLANTATION

Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role ofWT1expression

(2013) Sarah Pozzi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

(2012) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Donor lymphocyte infusions for relapse after allogeneic transplantation. When, if and for whom?

(2012) Ying-Jun Chang et al.   BLOOD REVIEWS

Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors

(2012) Chen-Hua Yan et al.   CLINICAL TRANSPLANTATION

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

(2010) David L. Porter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Donor lymphocyte infusions: the long and winding road: how should it be traveled?

(2008) M Tomblyn et al.   BONE MARROW TRANSPLANTATION